Literature DB >> 10090304

Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women.

M D Gammon1, H Hibshoosh, M B Terry, S Bose, J B Schoenberg, L A Brinton, J L Bernstein, W D Thompson.   

Abstract

p53 mutations may be a fingerprint for cigarette smoking and other environmental carcinogens, including breast carcinogens. This study was undertaken to explore whether p53 mutations are associated with environmental or other suspected or established risk factors for breast cancer. p53 protein detection by immunohistochemistry (which is more easily quantified in large epidemiological studies than are mutations, and are highly correlated with them) was determined for 378 patients from a case-control study of breast cancer. In this population-based sample of women under the age of 45 years, 44.4% (168/378) of the cases had p53 protein detected by immunohistochemistry (p53+). Polytomous logistic regression was used to calculate the odds ratios (ORs) for p53+ and p53- breast cancer, as compared with the controls, in relation to cigarette smoking and other factors. The ratio of the ORs was used as an indicator of heterogeneity in risk for p53+ versus p53- cancer. The ratio of the ORs in a multivariate model was substantially elevated among women with a greater than high school education [2.39; 95% confidence interval (CI), 1.43-4.00], current cigarette smokers (1.96; 95% CI, 1.10-3.52), and users of electric blankets, water beds, or mattresses (1.78; 95% CI, 1.11-2.86). Nonsignificant heterogeneity was noted for family history of breast cancer and ethnicity but not for other known or suspected risk factors. Coupled with the strong biological plausibility of the association, our data support the hypothesis that in breast cancer, as with other tumors, p53 protein immunohistochemical detection may be associated with exposure to environmental carcinogens such as cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090304

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  14 in total

1.  How I nearly became a Marlboro man.

Authors:  J Safran
Journal:  Tob Control       Date:  2000-03       Impact factor: 7.552

2.  A conceptual and methodological framework for investigating etiologic heterogeneity.

Authors:  Colin B Begg; Emily C Zabor; Jonine L Bernstein; Leslie Bernstein; Michael F Press; Venkatraman E Seshan
Journal:  Stat Med       Date:  2013-07-16       Impact factor: 2.373

3.  Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer Study.

Authors:  Halei C Benefield; Emily C Zabor; Yue Shan; Emma H Allott; Colin B Begg; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-08       Impact factor: 4.254

4.  Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer.

Authors:  Mustafa Akkiprik; Ozgur Sonmez; Bahadir M Gulluoglu; Hale B Caglar; Handan Kaya; Pakize Demirkalem; Ufuk Abacioglu; Meric Sengoz; Aydin Sav; Ayse Ozer
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

5.  Adiposity is associated with p53 gene mutations in breast cancer.

Authors:  Heather M Ochs-Balcom; Catalin Marian; Jing Nie; Theodore M Brasky; David S Goerlitz; Maurizio Trevisan; Stephen B Edge; Janet Winston; Deborah L Berry; Bhaskar V Kallakury; Jo L Freudenheim; Peter G Shields
Journal:  Breast Cancer Res Treat       Date:  2015-09-12       Impact factor: 4.872

6.  Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.

Authors:  Huiyan Ma; Yaping Wang; Jane Sullivan-Halley; Linda Weiss; Polly A Marchbanks; Robert Spirtas; Giske Ursin; Ronald T Burkman; Michael S Simon; Kathleen E Malone; Brian L Strom; Jill A McDonald; Michael F Press; Leslie Bernstein
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

7.  Expression profile of BRCA1 and BRCA2 genes in premenopausal Mexican women with breast cancer: clinical and immunohistochemical correlates.

Authors:  Gloria Loredo-Pozos; Erwin Chiquete; Antonio Oceguera-Villanueva; Arturo Panduro; Fernando Siller-López; Martha E Ramos-Márquez
Journal:  Med Oncol       Date:  2008-11-15       Impact factor: 3.064

8.  Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.

Authors:  Edward R Sauter; David S Tichansky; Inna Chervoneva; Eleftherios P Diamandis
Journal:  Environ Health Perspect       Date:  2002-03       Impact factor: 9.031

9.  Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumors.

Authors:  Irina Mordukhovich; Pavel Rossner; Mary Beth Terry; Regina Santella; Yu-Jing Zhang; Hanina Hibshoosh; Lorenzo Memeo; Mahesh Mansukhani; Chang-Min Long; Gail Garbowski; Meenakshi Agrawal; Mia M Gaudet; Susan E Steck; Sharon K Sagiv; Sybil M Eng; Susan L Teitelbaum; Alfred I Neugut; Kathleen Conway-Dorsey; Marilie D Gammon
Journal:  Environ Health Perspect       Date:  2009-11-18       Impact factor: 9.031

10.  Mutations in p53, p53 protein overexpression and breast cancer survival.

Authors:  Pavel Rossner; Marilie D Gammon; Yu-Jing Zhang; Mary Beth Terry; Hanina Hibshoosh; Lorenzo Memeo; Mahesh Mansukhani; Chang-Min Long; Gail Garbowski; Meenakshi Agrawal; Tara S Kalra; Mia M Gaudet; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  J Cell Mol Med       Date:  2008-10-16       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.